Posts - Bleeding Disorders

Jan 24, 2022 4:46pm
This article in Blood illustrates the disparity between chromogenic and clot-based factor VIII assays when measuring factor VIII activity produced by hemophilic recipients of gene transfer factor VIII: Rosen S, Tiefenbacker S, Robinson M, et al.
0 Comments
Jan 21, 2022 3:41pm
Click here to see Biomarin's 1-9-22 announcement of their 134-participant factor VIII gene transfer trial, valoctocogene roxaparvovec. Thanks to Dean Willett, Precision BioLogic Inc. for alerting us to this encouraging development.
0 Comments
Dec 18, 2021 7:31am
Thanks to Dean Willett, Precision BioLogic Inc. for this heads-up. Dean alerts us to this press release [click] outlining Sigilon’s decision to terminate their hemophilia program.
0 Comments
Nov 22, 2021 11:16am
This case study is the first instance I've [Geo] seen describing the development of an anti-emicizumab antibody that appears to suppress hemophilia A therapy: /sites/default/files/anti-emicizumab_kaneda_jth_2021.pdf
0 Comments